Loading...
XSHG
600129
Market cap1.25bUSD
Jul 10, Last price  
16.58CNY
1D
2.87%
1Q
-6.56%
Jan 2017
-10.26%
Name

Chongqing Taiji Industry(Group)Co.

Chart & Performance

D1W1MN
XSHG:600129 chart
P/E
75.83
P/S
0.88
EPS
0.22
Div Yield, %
1.95%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
-1.39%
Revenues
10.45b
-15.65%
4,078,194,3654,504,415,6824,814,879,5905,275,145,7125,985,619,8246,385,801,3546,602,726,8586,603,077,7146,958,053,4797,171,457,1997,951,835,6478,773,263,62110,689,384,28111,643,087,42611,207,803,71012,149,432,71814,127,402,32915,622,648,41612,386,016,98310,448,111,281
Net income
121m
+352.37%
63,259,15363,591,64423,501,00037,699,879-161,585,70920,679,704-220,449,94812,559,824-276,635,697231,606,902856,210,86397,738,75270,263,499-70,830,33266,067,064-523,174,253354,381,880822,124,92526,652,733120,570,288
CFO
587m
P
273,533,360240,007,181297,456,589338,274,782124,967,518172,379,99880,079,87000000104,409,864327,246,057749,791,289558,812,7951,800,768,932671,536,615-631,462,933587,241,863
Dividend
Jun 07, 20240.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chongqing Taiji Industry (Group) Co.,Ltd operates as a pharmaceutical enterprise, conducting business both within China and across international markets. The company focuses on the research, development, manufacturing, and distribution of traditional Chinese medicines and various health products. Its offerings are available in a wide array of formats, including tablets, oral liquids, syrups, dripping pills, granules, capsules, tinctures, and powders. The product line addresses a comprehensive range of health conditions and therapeutic areas. These include disorders of the digestive and respiratory systems, cardiovascular and cerebrovascular ailments, pediatric and gynecological health, systemic anti-infective agents and antibiotics, pain relief medications, orthopedic treatments, remedies for colds and coughs, and drugs for the endocrine and nervous systems. The firm's headquarters are situated in Chongqing, China.
IPO date
Nov 18, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT